Search clinical trials for: Ulthera System Treatment
Total 87848 results
-
Memorial Sloan Kettering Cancer CenterCompletedSarcoma | Lymphoma | Kidney Cancer | Testicular Germ Cell Tumor | Head and Neck Cancer | Ovarian Cancer | Neuroblastoma | Retinoblastoma | Liver Cancer | Extragonadal Germ Cell Tumor | Childhood Germ Cell TumorUnited States
-
Fox Chase Cancer CenterNational Cancer Institute (NCI)CompletedLung Cancer | Carcinoma of Unknown PrimaryUnited States
-
Inje UniversityUnknownNon Hodgkin's LymphomaKorea, Republic of
-
M.D. Anderson Cancer CenterBayerTerminated
-
Memorial Sloan Kettering Cancer CenterCompletedAcute Myeloid Leukemia | Advanced Myelodysplastic SyndromesUnited States
-
National Institute of Allergy and Infectious Diseases...RecruitingChronic Granulomatous DiseaseUnited States
-
Memorial Sloan Kettering Cancer CenterMerck Sharp & Dohme LLCRecruitingHodgkin Lymphoma | Relapsed or Refractory Hodgkin LymphomaUnited States
-
University of SaskatchewanNot yet recruitingMetastatic Colorectal Cancer
-
Hackensack Meridian HealthMillennium Pharmaceuticals, Inc.CompletedMultiple MyelomaUnited States
-
M.D. Anderson Cancer CenterCompletedLymphoma | Disorder Related to Bone Marrow TransplantationUnited States
-
M.D. Anderson Cancer CenterNovartisCompleted
-
Washington University School of MedicineCompletedLymphoma, Non-Hodgkin | Multiple MyelomaUnited States
-
AIDS Malignancy ConsortiumNational Cancer Institute (NCI)Withdrawn
-
Baylor College of MedicineCompleted
-
Case Comprehensive Cancer CenterNational Cancer Institute (NCI)Completed
-
National Cancer Institute (NCI)CompletedStage IV Renal Cell Cancer | Recurrent Renal Cell CancerUnited States
-
Institut Paoli-CalmettesCompletedLymphoma | Myelodysplastic Syndromes | Leukemia | Chronic Myeloproliferative Disorders | Multiple Myeloma and Plasma Cell Neoplasm | Myelodysplastic/Myeloproliferative NeoplasmsFrance
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)CompletedChronic Myeloproliferative DisordersUnited States, United Kingdom, France
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)Completed
-
Eastern Cooperative Oncology GroupNational Cancer Institute (NCI); Cancer and Leukemia Group BCompleted
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingRefractory Hodgkin Lymphoma | Refractory T-Cell Non-Hodgkin Lymphoma | Recurrent Diffuse Large B-Cell Lymphoma | Refractory Diffuse Large B-Cell Lymphoma | Recurrent T-Cell Non-Hodgkin LymphomaUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)RecruitingRefractory Plasma Cell Myeloma | Recurrent Plasma Cell MyelomaUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)RecruitingHead and Neck Carcinoma | Oropharyngeal Carcinoma | Cranial Nerve DisorderUnited States
-
National Cancer Institute (NCI)CompletedAnemia | Refractory Multiple Myeloma | Recurrent Multiple MyelomaUnited States
-
PfizerCompletedRespiratory Syncytial Virus InfectionsUnited Kingdom
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)CompletedLymphoma | LeukemiaUnited States
-
Eastern Cooperative Oncology GroupTerminated
-
University Hospital Schleswig-HolsteinDeutsche Krebshilfe e.V., Bonn (Germany)CompletedLeukemiaIsrael, Germany, Italy, Australia, Austria, Czechia, Switzerland
-
Mayo ClinicNational Cancer Institute (NCI)CompletedPlasma Cell Myeloma | Smoldering Plasma Cell Myeloma | Indolent Plasma Cell MyelomaUnited States
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)CompletedRefractory Plasma Cell Myeloma | DS Stage I Plasma Cell Myeloma | DS Stage II Plasma Cell Myeloma | DS Stage III Plasma Cell MyelomaUnited States
-
Mayo ClinicNational Cancer Institute (NCI)Completed
-
M.D. Anderson Cancer CenterNovartisCompletedLeukemia | Acute Lymphocytic LeukemiaUnited States
-
National Heart, Lung, and Blood Institute (NHLBI)CompletedHeart Diseases | Cardiovascular Diseases | Atrial Fibrillation | Arrhythmia
-
University of MiamiCompleted
-
M.D. Anderson Cancer CenterNovartis PharmaceuticalsCompleted
-
Southwest Oncology GroupNational Cancer Institute (NCI)CompletedLeukemia | Thrombocytopenia | NeutropeniaUnited States
-
Biosense Webster, Inc.CompletedParoxysmal Atrial FibrillationUnited States, France, Switzerland
-
University Hospital OstravaNot yet recruitingCardiovascular Diseases | Heart Failure With Reduced Ejection FractionCzechia
-
Emory UniversityNational Cancer Institute (NCI)RecruitingMetastatic Malignant Solid Neoplasm | Metastatic Malignant Neoplasm in the BrainUnited States
-
Multiple Myeloma Research ConsortiumEli Lilly and Company; GlaxoSmithKline; AbbVie; Takeda; Genentech, Inc.; Celgene Corporation and other collaboratorsRecruitingRelapsed Refractory Multiple MyelomaUnited States
-
University of California, San FranciscoJanssen Pharmaceuticals; Multiple Myeloma Research FoundationTerminatedRefractory Plasma Cell Myeloma | Recurrent Plasma Cell MyelomaUnited States
-
Mayo ClinicNational Cancer Institute (NCI)Active, not recruitingRefractory Plasma Cell MyelomaUnited States
-
Mayo ClinicMultiple Myeloma Research FoundationCompletedRecurrent Plasma Cell Myeloma | t(11;14)United States
-
Andrei IagaruGeneral ElectricCompletedBreast Carcinoma | Estrogen Receptor PositiveUnited States
-
Mayo ClinicNational Cancer Institute (NCI)Active, not recruitingIdasanutlin, Ixazomib Citrate, and Dexamethasone in Treating Patients With Relapsed Multiple MyelomaRecurrent Plasma Cell Myeloma | Loss of Chromosome 17pUnited States
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedLeukemiaUnited States, Canada, Australia, Switzerland, Puerto Rico, Netherlands
-
Academic and Community Cancer Research UnitedNational Cancer Institute (NCI); Janssen Scientific Affairs, LLCWithdrawnRecurrent Plasma Cell MyelomaUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)WithdrawnRecurrent Acute Myeloid LeukemiaUnited States
-
National Institute of Allergy and Infectious Diseases...CompletedHIV Infections | Lymphoma, Non-HodgkinUnited States
-
Ohio State University Comprehensive Cancer CenterCelgeneCompletedRecurrent Plasma Cell MyelomaUnited States